Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II, Open-Label, Single Arm Decentralized Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04644315
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:38.803343+00:00
Published At
2023-08-07T00:00:00+00:00
Record Updated At
2023-08-07
Results Posted At
2023-08-07
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Neoplasms", "Colorectal Neoplasms", "Melanoma", "Pancreatic Neoplasms", "Sarcoma", "Ovarian Neoplasms", "Brain Neoplasms", "Thyroid Neoplasms", "Neuroendocrine Tumors", "Cholangiocarcinoma", "Salivary Gland Neoplasms", "Head and Neck Neoplasms", "Thyroid Cancer, Papillary", "Lymphoma, Large-Cell, Anaplastic", "Neoplasms by Site", "Respiratory Tract Neoplasms", "Thoracic Neoplasms", "Respiratory Tract Diseases", "Carcinoma, Bronchogenic", "Bronchial Neoplasms", "Intestinal Neoplasms", "Gastrointestinal Neoplasms", "Digestive System Neoplasms", "Digestive System Diseases", "Gastrointestinal Diseases", "Colonic Diseases", "Intestinal Diseases", "Central Nervous System"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-08-07"
protocolSection.identificationModule.nctId
"NCT04644315"
protocolSection.identificationModule.officialTitle
"A Phase II, Open-Label, Single Arm Decentralized Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2023-08-07"

Study condition terms

  • Neoplasms (protocolSection.conditionsModule.conditions)
  • Colorectal Neoplasms (protocolSection.conditionsModule.conditions)
  • Melanoma (protocolSection.conditionsModule.conditions)
  • Pancreatic Neoplasms (protocolSection.conditionsModule.conditions)
  • Sarcoma (protocolSection.conditionsModule.conditions)
  • Ovarian Neoplasms (protocolSection.conditionsModule.conditions)
  • Brain Neoplasms (protocolSection.conditionsModule.conditions)
  • Thyroid Neoplasms (protocolSection.conditionsModule.conditions)
  • Neuroendocrine Tumors (protocolSection.conditionsModule.conditions)
  • Cholangiocarcinoma (protocolSection.conditionsModule.conditions)
  • Salivary Gland Neoplasms (protocolSection.conditionsModule.conditions)
  • Head and Neck Neoplasms (protocolSection.conditionsModule.conditions)
  • Thyroid Cancer, Papillary (protocolSection.conditionsModule.conditions)
  • Lymphoma, Large-Cell, Anaplastic (protocolSection.conditionsModule.conditions)
  • Neoplasms by Site (protocolSection.conditionsModule.conditions)
  • Respiratory Tract Neoplasms (protocolSection.conditionsModule.conditions)
  • Thoracic Neoplasms (protocolSection.conditionsModule.conditions)
  • Respiratory Tract Diseases (protocolSection.conditionsModule.conditions)
  • Carcinoma, Bronchogenic (protocolSection.conditionsModule.conditions)
  • Bronchial Neoplasms (protocolSection.conditionsModule.conditions)
  • Intestinal Neoplasms (protocolSection.conditionsModule.conditions)
  • Gastrointestinal Neoplasms (protocolSection.conditionsModule.conditions)
  • Digestive System Neoplasms (protocolSection.conditionsModule.conditions)
  • Digestive System Diseases (protocolSection.conditionsModule.conditions)
  • Gastrointestinal Diseases (protocolSection.conditionsModule.conditions)
  • Colonic Diseases (protocolSection.conditionsModule.conditions)
  • Intestinal Diseases (protocolSection.conditionsModule.conditions)
  • Central Nervous System (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.